Development of retrovirus vectors useful for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo
- PMID: 3418785
- PMCID: PMC253524
- DOI: 10.1128/JVI.62.10.3795-3801.1988
Development of retrovirus vectors useful for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo
Abstract
A series of retrovirus vectors were constructed in which cellular promoter elements derived from the chicken beta-actin and human histone H4 genes were introduced within the proviral transcriptional unit of Moloney murine leukemia virus in order to promote expression of inserted sequences. Each of these vectors gave rise to high titer of virus capable of transferring the expected proviral structure to cells. Inclusion of normal 5' splice sequences or a portion of viral gag sequences in these constructions resulted in significant increases in virus titer. Each construction was transcriptionally active in NIH 3T3 cells and in undifferentiated F9 cells. One of the vectors, HSG-neo, which contained the human histone H4 promoter, was shown to be transcriptionally active in hematopoietic cells derived from long-term reconstituted bone marrow transplant recipients engrafted with transduced stem cells. These vectors should be of general use for obtaining efficient gene expression in embryonal and hematopoietic cells.
Similar articles
-
Retroviral vector design for long-term expression in murine hematopoietic cells in vivo.Blood. 1994 Sep 15;84(6):1812-22. Blood. 1994. PMID: 8080986
-
Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays.J Virol. 1989 May;63(5):2317-24. doi: 10.1128/JVI.63.5.2317-2324.1989. J Virol. 1989. PMID: 2704078 Free PMC article.
-
Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.J Virol. 1995 Dec;69(12):7541-7. doi: 10.1128/JVI.69.12.7541-7547.1995. J Virol. 1995. PMID: 7494260 Free PMC article.
-
Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection.J Hematother. 1996 Aug;5(4):323-9. doi: 10.1089/scd.1.1996.5.323. J Hematother. 1996. PMID: 8877707 Review.
-
Retroviral-mediated gene transfer into mammalian cells.Blood Cells. 1987;13(1-2):285-98. Blood Cells. 1987. PMID: 3311223 Review.
Cited by
-
Development of a retroviral vector for inducible expression of transforming growth factor beta 1.J Virol. 1990 Jul;64(7):3527-31. doi: 10.1128/JVI.64.7.3527-3531.1990. J Virol. 1990. PMID: 2352331 Free PMC article.
-
Expression of phosphoenolpyruvate carboxykinase (PEPCK) chimeras in renal epithelial cells. Retention of appropriate physiological responsiveness using enhancerless retroviral vectors.Biochem J. 1992 Jun 15;284 ( Pt 3)(Pt 3):725-32. doi: 10.1042/bj2840725. Biochem J. 1992. PMID: 1377912 Free PMC article.
-
Gene therapy vectors as drug delivery systems.Clin Pharmacokinet. 1995 Mar;28(3):181-9. doi: 10.2165/00003088-199528030-00001. Clin Pharmacokinet. 1995. PMID: 7758249 Review. No abstract available.
-
Expression of human adenosine deaminase in mice transplanted with hemopoietic stem cells infected with amphotropic retroviruses.J Exp Med. 1990 Sep 1;172(3):729-36. doi: 10.1084/jem.172.3.729. J Exp Med. 1990. PMID: 1974914 Free PMC article.
-
KappaBle fluorescent reporter mice enable low-background single-cell detection of NF-κB transcriptional activity in vivo.Mucosal Immunol. 2022 Apr;15(4):656-667. doi: 10.1038/s41385-022-00525-8. Epub 2022 May 19. Mucosal Immunol. 2022. PMID: 35589985 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous